Anesthesia & Pain Research
Open Access
ISSN: 2639-846X
Case Report
View / Download PDF
Case Report: Suspected Anaphylaxis after Administration of Sugammadex
Authors: Osama Elsayed.
Abstract
Anaphylaxis is a severe, life-threatening hypersensitivity reaction that can occur rapidly after exposure to an allergen. Sugammadex is a novel neuromuscular blockade reversal agent used to counteract the effects of amino steroid muscle relaxants such as rocuronium and vecuronium. Although generally considered safe, there have been rare reports of anaphylaxis following sugammadex administration. This case report describes an incident of anaphylaxis triggered by sugammadex, highlighting the clinical presentation, management, and potential implications for anesthesia practice.
Citation:
Osama Elsayed. Case Report: Suspected Anaphylaxis after Administration of Sugammadex. 2024; 8(2).
DOI:
10.33425/2639-846X.1086
Editor-in-Chief
Kevin J. Sullivan
Pediatric Cardiac Anesthesiology and Pediatric Cardiac Critical Care Medicine | University of Florida
View full editorial board →
Journal Metrics
Impact Factor
3.3*
Acceptance Rate
78%
Time to first decision
6-8 Days
Submission to acceptance
10-12 Days